DRUG DES DEV THER 润色咨询

Drug Design Development and Therapy

出版年份：2007 年文章数：2918 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：2.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2026-06-10 ms5000000189005011 来自辽宁省

    不收meta，别投

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2025-08-04 ms8000000289511534 来自四川省

    请问1ee状态大家持续了好久呀

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2022-02-14 ms8000000079549416

    5天都是1A,而且只有通讯作者收到了邮件，这个怎么办

    10

    展开10条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2025-07-17 ms8000000453181943 来自辽宁省

    偏重的研究方向：网药;药理;中药
    经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2024-07-25 148817e2m02暂无昵称 来自江苏省

    偏重的研究方向：药物;药物治疗
    经验分享：大家好，请问大家1A1状态一般持续多久呀

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2025-05-20 匿名用户

    拒稿说不收bib这种文章类型

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2025-03-31 ms8000000453181943 来自北京

    偏重的研究方向：网药;中药
    经验分享：修回后编辑做决定都半个多月了正常吗

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2022-02-16 审稿人爸爸求求您

    1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的

    10

    展开10条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2023-09-20 41982559 来自广东省

    偏重的研究方向：药理
    经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2324776, encodeId=595a2324e76d8, content=不收meta，别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=41085509536, createdName=ms5000000189005011, createdTime=Wed Jun 10 22:28:22 CST 2026, time=2026-06-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2276001, encodeId=983722e6001fa, content=请问1ee状态大家持续了好久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83988836455, createdName=ms8000000289511534, createdTime=Mon Aug 04 15:08:33 CST 2025, time=2025-08-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1193164, encodeId=55ac1193164dd, content=5天都是1A,而且只有通讯作者收到了邮件，这个怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ddf6446359, createdName=ms8000000079549416, createdTime=Mon Feb 14 01:09:27 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2273701, encodeId=6ed522e370131, content=偏重的研究方向：网药;药理;中药<br>经验分享：经验分享：原始研究，相比工作量更看重创新性。从投稿到录用8个月，前4个月非常快，补实验一个月，回复完外审的意见。剩下4个月就是挤牙膏式的编辑提问，回复了四次，都是统计学的问题，每次一个问题，我很快就回复过去，然后编辑要2-3周才会回复我，就这样拖了4个月，其实他的问题本可以一次说完的，非常简单的问题，有的问题像是有模版，总体感觉好坏参半吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Thu Jul 17 10:50:47 CST 2025, time=2025-07-17, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2216779, encodeId=68d12216e799f, content=偏重的研究方向：药物;药物治疗<br>经验分享：大家好，请问大家1A1状态一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=278, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=148817e2m02暂无昵称, createdTime=Thu Jul 25 14:00:49 CST 2024, time=2024-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2265827, encodeId=1e89226582eee, content=拒稿说不收bib这种文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Tue May 20 09:12:26 CST 2025, time=2025-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2258592, encodeId=db7522585923a, content=偏重的研究方向：网药;中药<br>经验分享：修回后编辑做决定都半个多月了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e89494357, createdName=ms8000000453181943, createdTime=Mon Mar 31 21:48:30 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1194025, encodeId=8aeb119402561, content=1e状态好几天，原始数据文件太大，上传不了，大家都是怎么上传的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54675539272, createdName=审稿人爸爸求求您, createdTime=Wed Feb 16 14:13:10 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158717, encodeId=d2192158e175c, content=偏重的研究方向：药理<br>经验分享：请问大家除了wb外，是否需要上传试剂盒等数据吗？我想上传但没找到这部分的作者须知。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=feb55120331, createdName=41982559, createdTime=Wed Sep 20 14:52:33 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2220819, encodeId=22352220819ed, content=请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Sat Aug 17 14:11:06 CST 2024, time=2024-08-17, status=1, ipAttribution=吉林省)]
    2024-08-17 ms9000001638905587 来自吉林省

    请问一下我在此期刊撤过稿一次，我又有一篇文章，再投的话会不会受到偏见，

    1

    展开1条回复
共433条页码: 1/44页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分